Cross Country Healthcare, Inc.
General ticker "CCRN" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $361.8M (TTM average)
Cross Country Healthcare, Inc. follows the US Stock Market performance with the rate: 13.6%.
Estimated limits based on current volatility of 0.0%: low 13.25$, high 13.25$
Factors to consider:
- Earnings expected soon, date: 2026-08-05 bmo
- Total employees count: 10113 (+339.7%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Public health crises, Economic downturns and volatility, Healthcare regulation reimbursement, Cybersecurity threats, Liquidity and credit risks
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.96$, 9.70$]
- 2026-12-31 to 2027-12-31 estimated range: [3.55$, 8.47$]
Financial Metrics affecting the CCRN estimates:
- Positive: with PPE of 403.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 18.45 > 12.98
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of 4.90 <= 5.54
- Negative: Shareholder equity ratio, % of 71.91 > 63.79
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: -9.07 < Industry operating profit margin (median), % of -0.34
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
Short-term CCRN quotes
Long-term CCRN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,019.73MM | $1,344.00MM | $1,054.29MM |
| Operating Expenses | $1,907.02MM | $1,360.87MM | $1,138.71MM |
| Operating Income | $112.71MM | $-16.86MM | $-84.41MM |
| Non-Operating Income | $-9.82MM | $0.47MM | $0.90MM |
| Interest Expense | $8.09MM | $2.19MM | $2.22MM |
| Income(Loss) | $102.89MM | $-16.40MM | $-83.51MM |
| Taxes | $30.26MM | $-1.84MM | $11.34MM |
| Net Income(Loss)* | $72.63MM | $-14.56MM | $-94.85MM |
| Stockholders Equity | $473.39MM | $418.96MM | $322.82MM |
| Assets | $679.32MM | $589.25MM | $448.95MM |
| Operating Cash Flow | $248.50MM | $120.12MM | $48.25MM |
| Capital expenditure | $13.97MM | $8.71MM | $8.16MM |
| Investing Cash Flow | $-13.78MM | $-8.71MM | $-8.16MM |
| Financing Cash Flow | $-221.24MM | $-46.85MM | $-13.01MM |
| Earnings Per Share** | $2.07 | $-0.44 | $-2.93 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.